lobbying_activities: 2646956
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2646956 | 7fcfa42e-7a57-4e0e-bf45-d7c0f7791c80 | 2A | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2021 | second_quarter | MMM | Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, Medicare Part D Non-Interference, health care reform, biosimilars, 340B, Sunshine, discount cards, MedPAC, coding, ASP, Part B, prescription drug access and affordability, transparency, international reference pricing, Stark & anti-kickback policies, home infusion, covid therapeutics and Medicare drug card H.R. 1319, American Rescue Plan of 2021 implementation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2021-07-19T14:05:28.917000-04:00 |